15 Feb

Government report on power morcellators highlights failures of FDA adverse event reporting

Feb. 14, 2017 – San Diego, CA — A new report from the Government Accountability Office (GAO) delves deep into the risks posed by power morcellators and exposes gaps within the...

14 Feb

DuPont agrees to $671 million settlement with plaintiffs injured by cancer-causing Teflon chemical

Feb. 13, 2017 – San Diego, CA — DuPont has agreed to pay more than $670 million in cash to settle thousands of lawsuits accusing the company of poisoning local water...

11 Feb

Xarelto maker stops latest trial early citing positive results

Feb. 10, 2017 – San Diego, CA — The results of the newest Xarelto clinical trial were so promising, Janssen Research & Development decided to end the trial early. Janssen is...

10 Feb

Elderly patients better off taking placebo in new Risperdal study

Feb. 9, 2017 – San Diego, CA — For elderly patients in palliative care, treating symptoms of delirium with the antipsychotic Risperdal may make some symptoms worse, a new study finds....

09 Feb

FDA speeds up recall process – now posts on website as soon as recall occurs

Feb. 8, 2017 -- San Diego, CA — U.S. consumers will now know when a medical device is recalled sooner than they had in the past. The U.S. Food and Drug...

08 Feb

What do lemons have to say about breast cancer? Apparently, a lot!

Feb. 7, 2017 -- San Diego, CA — The nonprofit group Worldwide Breast Cancer is using an unlikely source to make it easier for women to detect early breast cancer: lemons. It's all...

07 Feb

Farxiga plaintiffs denied ‘class-wide’ consolidation with Invokana request new MDL

Feb. 6, 2017 – San Diego, CA — People injured by the type II diabetes medication Farxiga may see their cases consolidated after all. One man suing AstraZeneca – the maker...

04 Feb

Will J&J try to settle the next Risperdal lawsuit before it heads to trial? [UPDATE]

[UPDATE] Feb. 22, 2017 — Johnson & Johnson settled the case one week before it went to trial. Read the story on our blog: J&J continues settlement trend, resolves another Risperdal lawsuit one...

03 Feb

Hernia mesh study shows risk of serious complications can outweigh benefits

Feb. 2, 2017 – San Diego, CA — The benefits of using surgical mesh to repair hernias may be outweighed by the risks of mesh complications, a Danish study suggests. The...

02 Feb

Alternative therapy to prevent chemo hair loss slapped with FDA warning; agency said device marketed without approval

Feb. 1, 2017 – San Diego, CA — The maker of a popular cold cap therapy for chemotherapy patients is under fire from the U.S. Food and Drug Administration. The company...

Categories

Recent post

What Our Clients Say